6-31138746-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_014068.3(PSORS1C1):c.134G>A(p.Arg45Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00074 in 1,613,990 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0038 ( 7 hom., cov: 32)
Exomes 𝑓: 0.00043 ( 4 hom. )
Consequence
PSORS1C1
NM_014068.3 missense
NM_014068.3 missense
Scores
2
1
14
Clinical Significance
Conservation
PhyloP100: -2.50
Genes affected
PSORS1C1 (HGNC:17202): (psoriasis susceptibility 1 candidate 1) This gene is one of several genes thought to confer susceptibility to psoriasis and systemic sclerosis, located on chromosome 6 near the major histocompatibility complex (MHC) class I region. [provided by RefSeq, Sep 2011]
PSORS1C2 (HGNC:17199): (psoriasis susceptibility 1 candidate 2) Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0028287172).
BP6
Variant 6-31138746-G-A is Benign according to our data. Variant chr6-31138746-G-A is described in ClinVar as [Benign]. Clinvar id is 784067.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAd4 at 7 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSORS1C1 | NM_014068.3 | c.134G>A | p.Arg45Gln | missense_variant | 5/6 | ENST00000259881.10 | NP_054787.2 | |
PSORS1C2 | NM_014069.3 | c.55+226C>T | intron_variant | ENST00000259845.5 | NP_054788.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PSORS1C1 | ENST00000259881.10 | c.134G>A | p.Arg45Gln | missense_variant | 5/6 | 1 | NM_014068.3 | ENSP00000259881.9 | ||
PSORS1C2 | ENST00000259845.5 | c.55+226C>T | intron_variant | 1 | NM_014069.3 | ENSP00000259845.4 |
Frequencies
GnomAD3 genomes AF: 0.00368 AC: 560AN: 152016Hom.: 6 Cov.: 32
GnomAD3 genomes
AF:
AC:
560
AN:
152016
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000911 AC: 227AN: 249046Hom.: 1 AF XY: 0.000630 AC XY: 85AN XY: 135022
GnomAD3 exomes
AF:
AC:
227
AN:
249046
Hom.:
AF XY:
AC XY:
85
AN XY:
135022
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000427 AC: 624AN: 1461856Hom.: 4 Cov.: 37 AF XY: 0.000367 AC XY: 267AN XY: 727234
GnomAD4 exome
AF:
AC:
624
AN:
1461856
Hom.:
Cov.:
37
AF XY:
AC XY:
267
AN XY:
727234
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00375 AC: 571AN: 152134Hom.: 7 Cov.: 32 AF XY: 0.00389 AC XY: 289AN XY: 74366
GnomAD4 genome
AF:
AC:
571
AN:
152134
Hom.:
Cov.:
32
AF XY:
AC XY:
289
AN XY:
74366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
45
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
142
Asia WGS
AF:
AC:
10
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
PSORS1C1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 25, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 04, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
PrimateAI
Benign
T
PROVEAN
Uncertain
D
REVEL
Benign
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Polyphen
B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at